Name | Relationship | Address | Signature | Signature date | CIK |
---|---|---|---|---|---|
McBride Dennis | Director | C/O NRX PHARMACEUTICALS, INC., 1201 ORANGE STREET STE 600, WILMINGTON | /s/ Dennis McBride | 2025-09-10 | 0002028250 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NRXP | Stock Option (right to buy) | Award | $0 | +25K | $0.00 | 25K | Apr 9, 2025 | Common Stock | 25K | $1.73 | Direct | F1 |
Id | Content |
---|---|
F1 | Represents stock options ("Options") granted pursuant to the Issuer's 2021 Omnibus Incentive Plan. The Options shall vest on April 9, 2026, subject to continued service to the Issuer. |